These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 27553101)

  • 41. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
    Hollowell M; Banno J; Marsy D; Shrestha N; Tan J; McNamara R; Decker J; Albano A; Franey L; Abdallah W; Loyaga-Rendon R; Chalfoun N; Fermin D
    Int J Cardiol; 2024 Sep; 411():132263. PubMed ID: 38878873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of unrecognised myocardial infarction detected by late gadolinium-enhanced MRI in diabetic patients with normal global and regional left ventricular systolic function.
    Yoon YE; Kitagawa K; Kato S; Nakajima H; Kurita T; Dohi K; Ito M; Sakuma H
    Eur Radiol; 2013 Aug; 23(8):2101-8. PubMed ID: 23553584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.
    Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H
    Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unrecognized myocardial scar by late-gadolinium-enhancement cardiovascular magnetic resonance: Insights from the population-based Hamburg City Health Study.
    Cavus E; Schneider JN; di Carluccio E; Ziegler A; Haack A; Ojeda F; Chevalier C; Jahnke C; Riedl KA; Radunski UK; Twerenbold R; Kirchhof P; Blankenberg S; Adam G; Tahir E; Lund GK; Muellerleile K
    J Cardiovasc Magn Reson; 2024; 26(1):101008. PubMed ID: 38341145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.
    Azuma M; Kato S; Sekii R; Kodama S; Kinoshita K; Suzurikawa K; Kagimoto M; Nakayama N; Iguchi K; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
    Int J Cardiovasc Imaging; 2021 Aug; 37(8):2535-2543. PubMed ID: 33725266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Utility of Cardiac MRI Myocardial Strain Parameters in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy: A Multicenter Study.
    Tang HS; Kwan CT; He J; Ng PP; Hai SHJ; Kwok FYJ; Sze HF; So MH; Lo HY; Fong HTA; Wan EYF; Lee CH; Yu EYT; Lai YTA; Lee CYJ; Leung ST; Chan HL; Tse HF; Pennell DJ; Mohiaddin RH; Senior R; Yan AT; Yiu KH; Ng MY
    AJR Am J Roentgenol; 2023 Apr; 220(4):524-538. PubMed ID: 36321987
    [No Abstract]   [Full Text] [Related]  

  • 50. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
    Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive Value of Cardiac Magnetic Resonance Imaging-Derived Myocardial Strain for Poor Outcomes in Patients with Acute Myocarditis.
    Lee JW; Jeong YJ; Lee G; Lee NK; Lee HW; Kim JY; Choi BS; Choo KS
    Korean J Radiol; 2017; 18(4):643-654. PubMed ID: 28670159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.
    Quail M; Grunseich K; Baldassarre LA; Mojibian H; Marieb MA; Cornfeld D; Soufer A; Sinusas AJ; Peters DC
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):2. PubMed ID: 30602395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
    Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac MRI Risk Stratification for Dilated Cardiomyopathy with Left Ventricular Ejection Fraction of 35% or Higher.
    Li S; Wang Y; Yang W; Zhou D; Zhuang B; Xu J; He J; Yin G; Fan X; Wu W; Sharma P; Sirajuddin A; Arai AE; Zhao S; Lu M
    Radiology; 2023 Mar; 306(3):e213059. PubMed ID: 36318031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement.
    Krittayaphong R; Chaithiraphan V; Maneesai A; Udompanturak S
    Int J Cardiovasc Imaging; 2011 Jun; 27(5):705-14. PubMed ID: 21479846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients.
    Pedrotti P; Vittori C; Facchetti R; Pedretti S; Dellegrottaglie S; Milazzo A; Frigerio M; Cipriani M; Giannattasio C; Roghi A; Rimoldi O
    Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):130-137. PubMed ID: 27625368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
    Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function.
    Ge Y; Antiochos P; Steel K; Bingham S; Abdullah S; Chen YY; Mikolich JR; Arai AE; Bandettini WP; Shanbhag SM; Patel AR; Farzaneh-Far A; Heitner JF; Shenoy C; Leung SW; Gonzalez JA; Shah DJ; Raman SV; Ferrari VA; Schulz-Menger J; Stuber M; Simonetti OP; Kwong RY
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2132-2145. PubMed ID: 32771575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.